Beijing Konruns Pharmaceutical Co., Ltd. Class ASSE: 603590

"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Results of the Initial Grant under the 2026 Restricted Share Incentive Plan

Sep 24, 2026 · Issued by Beijing Konruns Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 24, 2026

Announcement on Results of the Initial Grant under the 2026 Restricted Share Incentive Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Beijing Konruns Pharmaceutical Co., Ltd. Class A

"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Obtaining New Veterinary Drug Registration CertificateSep 16
"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Release of Trading Restrictions and Listing of Shares for the 3rd Lock-up Period of the Initial Grant under the 2023 Restricted Share Incentive PlanSep 15
"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Lifting of Restrictions and Listing of Shares for the Second Lock-up Period of Reserved Grant under the 2023 Restricted Share Incentive PlanAug 29
"Beijing Konruns Pharmaceutical Co., Ltd."Semi-annual Report for 2026Aug 26

All Beijing Konruns Pharmaceutical Co., Ltd. Class A news releases